JPMorgan Adds Positive Catalyst Watch on Tango Therapeutics Inc. (TNGX)

October 13, 2026 7:58 AM EDT Send to a Friend
JPMorgan analyst Brian Cheng reiterated an Overweight rating and $48.00 price target on Tango Therapeutics Inc. (NASDAQ: TNGX).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login